Yixuan Jia

Yixuan Jia

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Sensors
Verified
Journal Article
Open access
PDF file
YGYixing Gou
Yixing Gou
YJYixuan Jia
Yixuan Jia
PWPeng Wang
Peng Wang
CSChangku Sun
Changku Sun
Inertial microfluidics has become a popular topic in microfluidics research for its good performance in particle manipulation and its advantages of simple structure, high throughput, and freedom from an external field. Compared with traditional microfluidic devices, the flow field in inertial microfluidics is between Stokes state and turbulence, whereas the flow is still regarded as laminar. However, many mechanical effects induced by the inertial effect are difficult to observe in traditional microfluidics, making particle motion analysis in inertial microfluidics more complicated. In recent years, the inertial migration effect in straight and curved channels has been explored theoretically and experimentally to realize on-chip manipulation with extensive applications from the ordinary manipulation of particles to biochemical analysis. In this review, the latest theoretical achievements and force analyses of inertial microfluidics and its development process are introduced, and its applications in circulating tumor cells, exosomes, DNA, and other biological particles are summarized. Finally, the future development of inertial microfluidics is discussed. Owing to its special advantages in particle manipulation, inertial microfluidics will play a more important role in integrated biochips and biomolecule analysis.

13 December 2023 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
YJYixuan Jia
Yixuan Jia
ZLZongyu Li
Zongyu Li
AAAzadeh Akhavanallaf
Azadeh Akhavanallaf
JFJeffrey A. Fessler
Jeffrey A. Fessler
YDYuni K. Dewaraja
Yuni K. Dewaraja
Purpose: 90Y SPECT-based dosimetry following radioembolization (RE) in liver malignancies is challenging due to the inherent scatter and the poor spatial resolution of bremsstrahlung SPECT. This study explores a deep-learning-based absorbed dose-rate estimation method for 90Y that mitigates the impact of poor SPECT image quality on dosimetry and the accuracy–efficiency trade-off of Monte Carlo (MC)-based scatter estimation and voxel dosimetry methods. Methods: Our unified framework consists of three stages: convolutional neural network (CNN)-based bremsstrahlung scatter estimation, SPECT reconstruction with scatter correction (SC) and absorbed dose-rate map generation with a residual learning network (DblurDoseNet). The input to the framework is the measured SPECT projections and CT, and the output is the absorbed dose-rate map. For training and testing under realistic conditions, we generated a series of virtual patient phantom activity/density maps from post-therapy images of patients treated with 90Y-RE at our clinic. To train the scatter estimation network, we use the scatter projections for phantoms generated from MC simulation as the ground truth (GT). To train the dosimetry network, we use MC dose-rate maps generated directly from the activity/density maps of phantoms as the GT (Phantom + MC Dose). We compared performance of our framework (SPECT w/CNN SC + DblurDoseNet) and MC dosimetry (SPECT w/CNN SC + MC Dose) using normalized root mean square error (NRMSE) and normalized mean absolute error (NMAE) relative to GT. Results: When testing on virtual patient phantoms, our CNN predicted scatter projections had NRMSE of 4.0% ± 0.7% on average. For the SPECT reconstruction with CNN SC, we observed a significant improvement on NRMSE (9.2% ± 1.7%), compared to reconstructions with no SC (149.5% ± 31.2%). In terms of virtual patient dose-rate estimation, SPECT w/CNN SC + DblurDoseNet had a NMAE of 8.6% ± 5.7% and 5.4% ± 4.8% in lesions and healthy livers, respectively; compared to 24.0% ± 6.1% and 17.7% ± 2.1% for SPECT w/CNN SC + MC Dose. In patient dose-rate maps, though no GT was available, we observed sharper lesion boundaries and increased lesion-to-background ratios with our framework. For a typical patient data set, the trained networks took ~ 1 s to generate the scatter estimate and ~ 20 s to generate the dose-rate map (matrix size: 512 × 512 × 194) on a single GPU (NVIDIA V100). Conclusion: Our deep learning framework, trained using true activity/density maps, has the potential to outperform non-learning voxel dosimetry methods such as MC that are dependent on SPECT image quality. Across comprehensive testing and evaluations on multiple targeted lesions and healthy livers in virtual patients, our proposed deep learning framework demonstrated higher (66% on average in terms of NMAE) estimation accuracy than the current “gold-standard” MC method. The enhanced computing speed with our framework without sacrificing accuracy is highly relevant for clinical dosimetry following 90Y-RE.

20 May 2025 in EJNMMI Physics
Verified
Journal Article
Open access
ZLZongyu Li
Zongyu Li
YJYixuan Jia
Yixuan Jia
XXXiaojian Xu
Xiaojian Xu
JHJason Hu
Jason Hu
JFJeffrey A. Fessler
Jeffrey A. Fessler
YDYuni K. Dewaraja
Yuni K. Dewaraja
Purpose: This study addresses the challenge of extended SPECT imaging duration under low-count conditions, as encountered in Lu-177 SPECT imaging, by developing a self-supervised learning approach to synthesize skipped SPECT projection views, thus shortening scan times in clinical settings. Methods: We developed SpeRF, a SPECT reconstruction pipeline that integrates synthesized and measured projections, using a self-supervised coordinate-based learning framework inspired by Neural Radiance Fields (NeRF). For each single scan, SpeRF independently trains a multi-layer perceptron (MLP) to estimate skipped SPECT projection views. SpeRF was tested with various down-sampling factors (DFs = 2, 4, 8) on both Lu-177 phantom SPECT/CT measurements and clinical SPECT/CT datasets, from 11 patients undergoing [177Lu]Lu-DOTATATE and 6 patients undergoing [177Lu]Lu-PSMA-617 radiopharmaceutical therapy. Performance was evaluated both in projection space and by comparing reconstructed images using (1) all measured views (“Full”), (2) down-sampled measured views only (“Partial”), and partially measured views combined with skipped views (3) generated by linear interpolation (“LinInt”) and (4) synthesized by our method (“SpeRF”). Results: SpeRF projections demonstrated lower Normalized Root Mean Squared Difference (NRMSD) compared to the measured projections, than LinInt projections. Across various DFs, the NRMSD for SpeRF projections averaged 7% vs. 10% in phantom studies, 18% vs. 26% in DOTATATE patient studies, and 20% vs. 21% in PSMA-617 patient studies, compared to LinInt projections. For SPECT reconstructions, DF = 4 is recommended as the best trade-off between acquisition time and image quality. At DF = 4, in terms of Contrast-to-Noise Ratio relative to Full, SpeRF outperformed LinInt and Partial: (1) DOTATATE: 88% vs. 69% vs. 69% for lesions and 88% vs. 73% vs. 67% for kidney, (2) PSMA-617: 78% vs. 71% vs. 69% for lesions and 78% vs. 57% vs. 67% for organs, including kidneys, lacrimal glands, parotid glands, and submandibular glands. SpeRF slightly underestimated count recovery relative to Full, compared to Partial but still outperformed LinInt: (1) DOTATATE: 98% vs. 100% vs. 88% for lesions and 98% vs. 100% vs. 94% for kidney, (2) PSMA-617: 98% vs. 101% vs. 94% for lesions and 96% vs. 101% vs. 78% for organs. Conclusion: The proposed method, SpeRF, shows potential for significant reduction in acquisition time (up to a factor of 4) while maintaining quantitative accuracy in clinical SPECT protocols by allowing for the collection of fewer projections. The self-supervised nature of SpeRF, with data processed independently on each patient’s projection data, eliminates the need for extensive training datasets. The reduction in acquisition time is particularly relevant for imaging under low-count conditions and for protocols that require multiple-bed positions such as whole-body imaging.